A61P 1/06
Anti-spasmodics
Official title: Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
A61P1/06 (Anti-spasmodics) appears on 879 US grants and 1,314 published applications in this corpus.
Search patents in A61P- Granted patents
- 879
- Published applications
- 1,314
- Assignees
- 545
- Inventors
- 2,795
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 10 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 30 | 11 |
| 2002 | 22 | 24 |
| 2003 | 23 | 50 |
| 2004 | 20 | 83 |
| 2005 | 23 | 62 |
| 2006 | 27 | 72 |
| 2007 | 43 | 75 |
| 2008 | 33 | 77 |
| 2009 | 41 | 95 |
| 2010 | 56 | 115 |
| 2011 | 67 | 73 |
| 2012 | 48 | 80 |
| 2013 | 58 | 54 |
| 2014 | 49 | 54 |
| 2015 | 47 | 64 |
| 2016 | 31 | 50 |
| 2017 | 42 | 42 |
| 2018 | 42 | 37 |
| 2019 | 27 | 36 |
| 2020 | 20 | 32 |
| 2021 | 21 | 23 |
| 2022 | 11 | 31 |
| 2023 | 11 | 24 |
| 2024 | 14 | 19 |
| 2025 | 14 | 16 |
| 2026 | 5 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant fc fusion proteins25 Aug 2026US 12,714,739 B2Novartis AG
- Phenol derivative31 Mar 2026US 12,590,063 B2Sumitomo Pharma Co., Ltd.
- Systems and methods for treating an opioid-induced adverse pharmacodynamic response24 Mar 2026US 12,582,647 B2Purdue Pharma L. P.
- Texture modified food product17 Mar 2026US 12,575,593 B2I Cook Catering Services Pty Ltd
- Mixture of HMOS for improving the microbiota of pregnant women27 Jan 2026US 12,533,369 B2Glycom A/S
- 4-(3-cyanophenyl)-6-pyridinylpyrimidine mglu5 modulators30 Jul 2026US 2026/0217669 A1Nxera Pharma UK Limited
- Polymorphs of the hydrobromide salt of linaprazan glurate30 Jul 2026US 2026/0217705 A1Cinclus Pharma Holding AB (Publ)
- Phenol derivative2 Jul 2026US 2026/0184683 A1Sumitomo Pharma Co., Ltd.
- Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (il4r) antibody2 Jul 2026US 2026/0184797 A1Regeneron Pharmaceuticals, Inc.
- Compositions and uses thereof11 Jun 2026US 2026/0158020 A1
Most cited
By later US patents
- Optimal polymer mixtures for gastric retentive tablets223US 6,723,340 B2Depomed, Inc. · 2004
- Urologic irrigation solution and method for inhibition of pain, inflammation and spasm152US 5,858,017 AOmeros Medical Systems, Inc. · 1999
- Arthroscopic irrigation solution and method for inhibition of pain and inflammation140US 5,860,950 AOmeros Medical Systems, Inc. · 1999
- Methods for regulating gastrointestinal motility138US 6,858,576 B1Amylin Pharmaceuticals, Inc. · 2005
- Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids125US 5,792,795 ATillotts Pharma AG · 1998